Beth Marsh
Vice President, North America Sales and Marketing, Ophthalmology
Apellis Pharmaceuticals
Biography
Beth is an experienced commercial strategy and business development executive. She has been a key initial team member in five ophthalmic franchises/start-up organizations and has successfully launched numerous products. At Apellis, Beth leads the ophthalmic commercial organization as they launch SYFOVRE®, the first approved product to treat geographic atrophy. Prior to Apellis, Beth was Global Product Strategy Lead for development-stage programs within the Ophthalmology Franchise at Shire-Takeda. She has also held leadership roles at J&J, Novartis, and Santen.